Atezolizumab Safe, Beneficial Long-Term in mUC

FG_AUTHORS: Renal and Urology News

HTTP/1.1 200 OK Date: Tue, 13 Feb 2018 17:05:05 GMT Content-Type: text/html; charset=utf-8 Content-Length: 124817 Connection: keep-alive Set-Cookie: AWSALB=A4t4AMcwUsjsTFsKgogHwF3R6kMTvlJo5iHcZdbtHcGjY+ljVr76Zg+pLa9c+p50NMtq9JN7OfIC0zAIPOXLkYDJEwwnIVRYmjtl+9muZdGgQSa3MpQBEPwICAIJ; Expires=Tue, 20 Feb 2018 17:05:05 GMT; Path=/ Cache-Control: private Server: Microsoft-IIS/8.5 X-AspNetMvc-Version: 4.0 X-AspNet-Version: 4.0.30319 Set-Cookie: CustomModalRegistrationDelay3=true; expires=Wed, 14-Feb-2018 05:00:00 GMT; path=/ X-Powered-By: ASP.NET From: VM-Web3-RUN

Atezolizumab Safe, Beneficial Long-Term in mUC - Renal and Urology News

Read more https://www.renalandurologynews.com/metastatic-urothelial-carcinoma-atezolizumab-safety-efficacy-3-years/article/743957/

PUA Social Network

Twitter Facebook

Contact us

The Philippine Urological Association,Inc
3rd floor. PCS Bldg., 992 EDSA, Quezon City,
Metro Manila, PHILIPPINES 1105
View Map

+632-9256740 
+632-4544439
+63917-5244456

eMail us